Stimcell Energetics Inc.
Close on Oct 19, 2026
- Market cap
- $3.42M
- P/E (TTM)
- –
- Dividend yield
- –
About Stimcell Energetics
Surgical & Medical Instruments & Apparatus, SIC 3841
Stimcell Energetics Inc. is a biotechnology company dedicated to the research, development, and commercialization of therapeutic and wellness products based on microcurrent technology. Its core proprietary offering is eBalance Technology, designed to deliver bioelectric micro amperage current to support cellular function, assist in general wellness, relieve pain, and help manage complications related to diseases such as diabetes, neuropathy, and high blood pressure. The company develops hardware solutions including the eBalance Pro System, intended for healthcare practitioners in clinical settings, and the eBalance Home System, engineered for direct in-home use by patients.
The business operates as a development-stage company with no full-time employees, relying on its executive officers serving as independent consultants alongside third-party engineering and clinical contractors. Corporate activities and subsidiary operations extend across the United States and Canada, where manufacturing arrangements and clinical studies have taken place. Stimcell Energetics Inc. maintains its corporate incorporation under the laws of the State of Nevada.
Summary of the business section of Stimcell Energetics's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Stimcell Energetics Inc.
- Founded
- 2010
- Headquarters
- Vancouver, A1
- Address
- 820 - 1130 Pender Street, West V6E 4A4
- Phone
- (844) 238-2692
- Employees
- 1, May 31, 2015
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Nevada
- Fiscal year ends
- May 31
- Auditor
- DMCL LLP, Vancouver, Canada
Stock & identifiers
- Ticker
- STME
- Exchange
- OTC
- Shares outstanding
- 21M, Aug 31, 2026
- Public float
- $2.43M, Nov 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-15 reverse, Jan 14, 2025; 1-for-15 reverse, Nov 5, 2024
- SEC CIK
- 1493712
- EIN
- 38-3939625
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Amir Vahabzadeh | Director | 4,164,566 |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jan 15, 2026 | Late filing | Notification of late filing |
| Sep 2, 2025 | Late filing | Notification of late filing |
| Oct 15, 2024 | Name change | Name changed from Cell MedX Corp. to Stimcell Energetics Inc. |
| Aug 29, 2023 | Late filing | Notification of late filing |
| Aug 29, 2022 | Late filing | Notification of late filing |
| Aug 31, 2020 | Late filing | Notification of late filing |
| Aug 30, 2019 | Late filing | Notification of late filing |
| Apr 16, 2019 | Late filing | Notification of late filing |
| Aug 30, 2018 | Late filing | Notification of late filing |
| Aug 29, 2016 | Late filing | Notification of late filing |
| Sep 1, 2015 | Late filing | Notification of late filing |
| Dec 24, 2014 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Dec 3, 2014 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Oct 9, 2014 | Name change | Name changed from Sports Asylum, Inc. to Cell MedX Corp. |
| Apr 14, 2014 | Late filing | Notification of late filing |
| Mar 24, 2014 | Name change | Name changed from Plandel Resources, Inc. to Sports Asylum, Inc. |
| Jan 15, 2013 | Late filing | Notification of late filing |
| Oct 19, 2012 | Auditor change | Change in certifying accountant (8-K Item 4.01) |